ACTIVE

LUCIMED

Export PDF

Financial year 2025 · closed on 31/08/2025

Net result

932,9 k €

+382.7% YoY

Gross margin

1,5 M €

+227.6% YoY

Equity

2,6 M €

+54.9% YoY

Workforce

1,0 ETP

-47.4% YoY

What does LUCIMED do?

LUCIMED is a Public limited company incorporated in 2005. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wavre. It employs on average 1,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0873.183.112

Incorporation

14/04/2005

Legal form

Public limited company

Registered office

Rue de Genval 20
1301 Wavre · WallonieSee on map

Contributed capital

190 000,00 €

Latest accounts

31/08/2025

Average workforce

1,0 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 93040Sports activities and amusement and recreation activities 96040Physical well-being activities 96230Other personal service activities 46460Wholesale of pharmaceutical goods+2

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	1,5 M €	+228%	456,6 k €	-18.0%	557 k €	+11.2%	501 k €	+19.5%	419,2 k €	+5.2%	398,5 k €	+81.4%	219,8 k €	-32.7%	326,7 k €	+2.4%	319,1 k €	+22.1%	261,2 k €	+93.1%	135,3 k €	-5.6%	143,3 k €	-2.3%	146,6 k €	+102%	72,7 k €	-0.9%	73,4 k €	+226%	-58 k €	-199%	58,5 k €	-5.3%	61,7 k €	+1246%	4,6 k €
EBITDA	1,4 M €	+324%	331,2 k €	-20.6%	417,3 k €	+3.2%	404,2 k €	+31.4%	307,6 k €	+1.9%	302 k €	+343%	68,2 k €	-67.6%	210,6 k €	-6.9%	226,1 k €	+26.7%	178,4 k €	+1026%	15,8 k €	-34.1%	24,1 k €	-75.7%	99,2 k €	+1063%	8,5 k €	-79.5%	41,7 k €	+178%	-53,3 k €	-176%	70,3 k €	+23.4%	57 k €	+351%	-22,8 k €
Operating result	1,4 M €	+355%	300,6 k €	-20.7%	379 k €	+17.2%	323,5 k €	+31.3%	246,4 k €	-5.8%	261,6 k €	+1346%	18,1 k €	-90.5%	190,9 k €	-6.7%	204,7 k €	+26.0%	162,5 k €	+2794%	5,6 k €	-36.3%	8,8 k €	-89.7%	85,7 k €	+3169%	2,6 k €	-91.9%	32,3 k €	+141%	-78,4 k €	-249%	52,7 k €	+1474%	3,3 k €	+105%	-64,7 k €
Net result	932,9 k €	+383%	193,3 k €	-27.1%	265 k €	+32.3%	200,3 k €	-16.3%	239,2 k €	-5.5%	253,2 k €	+1564%	15,2 k €	-91.7%	182,3 k €	-6.6%	195,1 k €	+34.7%	144,8 k €	+5005%	2,8 k €	-59.4%	7 k €	-91.3%	80,7 k €	+1212%	6,1 k €	-82.8%	35,7 k €	+150%	-71,4 k €	-223%	57,9 k €	+415%	11,2 k €	+120%	-56,5 k €
Balance sheet
Equity	2,6 M €	+54.9%	1,7 M €	+12.8%	1,5 M €	+21.4%	1,2 M €	+19.3%	1 M €	+29.9%	800,5 k €	+23.7%	647,4 k €	-11.6%	732,2 k €	+33.2%	549,9 k €	+55.0%	354,8 k €	+69.0%	210 k €	+1.4%	207,1 k €	+3.5%	200,1 k €	+67.5%	119,5 k €	+5.4%	113,3 k €	+42.4%	79,6 k €	-48.7%	155,2 k €	+49.9%	103,6 k €	+6.6%	97,2 k €
Total assets	4,8 M €	+55.9%	3,1 M €	+15.6%	2,7 M €	+31.8%	2 M €	+61.7%	1,3 M €	+13.6%	1,1 M €	+16.7%	945,1 k €	-2.9%	972,9 k €	+26.1%	771,7 k €	+52.1%	507,5 k €	+55.3%	326,7 k €	+0.5%	325 k €	-4.0%	338,6 k €	+59.8%	211,9 k €	-5.1%	223,2 k €	+20.5%	185,1 k €	-11.0%	208 k €	-0.4%	208,8 k €	-5.9%	221,9 k €
Cash	531,2 k €	-44.0%	947,8 k €	+265%	259,7 k €	-29.2%	366,8 k €	-10.5%	409,8 k €	+138%	172,5 k €	+96.7%	87,7 k €	-22.2%	112,7 k €	+16.5%	96,7 k €	+45.5%	66,5 k €	+68.1%	39,5 k €	+17.5%	33,6 k €	-73.8%	128,4 k €	+2008%	6,1 k €	-37.3%	9,7 k €	+10.0%	8,8 k €	-79.4%	42,9 k €	+594%	6,2 k €	-84.9%	41 k €
Debts	2 M €	+66.5%	1,2 M €	+11.5%	1,1 M €	+42.3%	762,4 k €	+337%	174,6 k €	-4.8%	183,5 k €	-1.4%	186,1 k €	+45.7%	127,7 k €	+24.9%	102,2 k €	+236%	30,4 k €	-28.5%	42,6 k €	-13.5%	49,2 k €	-47.4%	93,4 k €	+56.2%	59,8 k €	-32.8%	89,1 k €	+37.2%	64,9 k €	+128%	28,5 k €	-38.7%	46,5 k €	-40.3%	77,8 k €
Other
Workforce	1,0 ETP	-47.4%	1,9 ETP	-24.0%	2,5 ETP	-3.8%	2,6 ETP	+62.5%	1,6 ETP	-38.5%	2,6 ETP	-7.1%	2,8 ETP	0.0%	2,8 ETP	+21.7%	2,3 ETP	+76.9%	1,3 ETP	-23.5%	1,7 ETP	-26.1%	2,3 ETP	+53.3%	1,5 ETP	+66.7%	0,9 ETP	-10.0%	1,0 ETP		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/08/2025 · 4 active · 23 ended

Active mandates

Eric DELLOYE

Chairman of the board of directors · since 08 novembre 2023 · until 08 novembre 2029

Active

Emmanuel DELLOYE

Managing director

Active

Jacques TILMAN

Director

Active

Monique TILMAN

Director

Active

Ended mandates

Eric Delloye

Director · since 01 avril 2016

Ended

ERIC DELLOYE

Director · since 01 avril 2016 · until 31 janvier 2022

Ended

EMMANUEL DELLOYE

Director · since 31 mars 2016 · until 31 janvier 2022

Ended

EMMANUEL DELLOYE

Managing director · since 31 mars 2016 · until 31 janvier 2022

Ended

At this address

Other companies at this address

Company	CBE no.
A.A.R.S. Sud - All Asbestos Removal Services Sud● Active	0785.561.824
ATELIER D'ARCHITECTURE BRUNO ERPICUM & PARTENAIRES● Active	0464.240.614
CASYS● Active	0473.622.492
C+CURE OPERATIONS● Active	0438.246.889
CONTINENTAL CARBON COMPANY EUROPE● Active	0564.992.237
CREA-NESS● Active	0544.965.596
DELTA EURO EVENTS● Active	0892.964.677
DE RIDDER CONCEPTS● Liquidation	0460.470.183
ELC GREEN LABEL● Active	0541.629.588
ENVIRONNEMENT ET PROMOTION IMMOBILIERE● Active	0438.370.615
ERPICUM● Active	0437.540.670
FoxPeak● Active	1038.721.035
GALATE● Active	0457.277.992
GDS Real Estate● Active	0668.779.465
INTERNATIONAL SERVICES & ADVICES● Active	0433.068.079
JLC WOOD● Active	0464.484.104
MOS IMMO● Active	0698.840.755
MULLER SERVICES● Active	0876.896.925
NEJEN CONSULTING● Active	0817.538.170
OPTIMUM FINANCE● Active	0873.561.412

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/09/2024	01/09/2023	01/09/2022	01/09/2021	01/09/2020	01/09/2019
Closing of the financial year	31/08/2025	31/08/2024	31/08/2023	31/08/2022	31/08/2021	31/08/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/04/2026	05/05/2026	05/05/2026	06/06/2023	31/03/2022	28/04/2021
General meeting	02/03/2026	03/03/2025	04/03/2024	10/03/2023	11/03/2022	12/02/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

23 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/08/2025	02/03/2026	28/04/2026	French	PDF
Abridged modelCorrection	31/08/2024	03/03/2025	05/05/2026	French	PDF
Abridged modelCorrection	31/08/2024	03/03/2025	04/09/2025	French	PDF
Abridged model	31/08/2024	03/03/2025	25/06/2025	French	PDF
Abridged modelCorrection	31/08/2023	04/03/2024	05/05/2026	French	PDF
Abridged model	31/08/2023	04/03/2024	30/05/2024	French	PDF
Abridged model	31/08/2022	10/03/2023	06/06/2023	French	PDF
Abridged model	31/08/2021	11/03/2022	31/03/2022	French	PDF
Abridged model	31/08/2020	12/02/2021	28/04/2021	French	PDF
Abridged model	31/08/2019	18/03/2020	26/03/2020	French	PDF
Abridged model	31/08/2018	22/02/2019	27/09/2019	French	PDF
Abridged model	31/08/2017	26/02/2018	16/07/2018	French	PDF
Abridged model	31/08/2016	20/02/2017	28/04/2017	French	PDF
Abridged model	31/08/2015	05/02/2016	08/06/2016	French	PDF
Abridged model	31/08/2014	30/03/2015	31/07/2015	French	PDF
Abridged model	31/08/2013	21/04/2014	22/05/2014	French	PDF
Abridged model	31/08/2012	27/02/2013	22/05/2014	French	PDF
Abridged model	31/08/2011	23/01/2012	16/02/2012	French	PDF
Abridged model	31/08/2010	29/03/2011	31/03/2011	French	PDF
Abridged model	31/08/2009	26/02/2010	26/02/2010	French	PDF
Abridged model	31/08/2008	30/03/2009	30/03/2009	French	PDF
Abridged model	31/08/2007	28/01/2008	27/02/2008	French	PDF
Abridged model	31/08/2006	29/01/2007	15/02/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/08/2025 · 4 active · 23 ended

Active mandates

Eric DELLOYE

Chairman of the board of directors · since 08 novembre 2023 · until 08 novembre 2029

Active

Emmanuel DELLOYE

Managing director

Active

Jacques TILMAN

Director

Active

Monique TILMAN

Director

Active

Ended mandates

Eric Delloye

Director · since 01 avril 2016

Ended

ERIC DELLOYE

Director · since 01 avril 2016 · until 31 janvier 2022

Ended

EMMANUEL DELLOYE

Director · since 31 mars 2016 · until 31 janvier 2022

Ended

EMMANUEL DELLOYE

Managing director · since 31 mars 2016 · until 31 janvier 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other14/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates01/04/2022
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates08/12/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates02/05/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates21/05/2014
DEMISSIONS, NOMINATIONS
PDF
Mandates06/04/2010
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates03/09/2007
DEMISSIONS, NOMINATIONS
PDF
Registered office08/02/2007
SIEGE SOCIAL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025932,9 k €↑
2024
Annual accounts 2024193,3 k €↓
2023
Annual accounts 2023265 k €↑
2023
Name changeLUCIMED (archived 13/05/2024 - 07:11)
2022
Annual accounts 2022200,3 k €↓
2022
Name changeLUCIMED
2021
Annual accounts 2021239,2 k €↓
2020
Annual accounts 2020253,2 k €↑
2019
Annual accounts 201915,2 k €↓
2018
Annual accounts 2018182,3 k €↓
2017
Annual accounts 2017195,1 k €↑
2016
Annual accounts 2016144,8 k €↑
2015
Annual accounts 20152,8 k €↓
2014
Annual accounts 20147 k €↓
2013
Annual accounts 201380,7 k €↑
2012
Annual accounts 20126,1 k €↓
2011
Annual accounts 201135,7 k €↑
2010
Annual accounts 2010-71,4 k €↓
2009
Annual accounts 200957,9 k €↑
2008
Annual accounts 200811,2 k €↑
2007
Annual accounts 2007-56,5 k €
14/04/2005
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

LUCIMED

Overview

What does LUCIMED do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline